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Abstract: Cases reporting traumatic injuries to the brain and spinal cord are extended range of disorders that affect a large 
percentage of the world’s population. But, there are only few effective treatments available for central nervous system (CNS) 
injuries because the CNS is refractory to axonal regeneration and relatively inaccessible to many pharmacological treatments. 
The use of stem cell therapy in regenerative medicine has been extensively examined to replace lost cells during CNS injuries. 
But, given the complexity of CNS injuries oxidative stress, toxic byproducts, which prevails in the microenvironment during 
the diseased condition, may limit the survival of the transplanted stem cells affecting tissue regeneration and even longevity. 
Carbon nanotubes (CNT) are a new class of nanomaterials, which have been shown to be promising in different areas of 
nanomedicine for the prevention, diagnosis and therapy of certain diseases, including CNS diseases. In particular, the use 
of CNTs as substrates/scaffolds for supporting the stem cell differentiation has been an area of active research. Single-walled 
and multi-walled CNT’s have been increasingly used as scaffolds for neuronal growth and more recently for neural stem cell 
growth and differentiation. This review summarizes recent research on the application of CNT-based materials to direct the 
differentiation of progenitor and stem cells toward specific neurons and to enhance axon regeneration and synaptogenesis 
for the effective treatment of CNS injuries. Nonetheless, accumulating data support the use of CNTs as a biocompatible and 
permissive substrate/scaffold for neural cells and such application holds great potential in neurological research.
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when inflicted with lesions resulting from trauma, stroke, 
or neuropathological conditions. Repair from CNS injuries 
is complicated because of the activation of inhibitors for 
nerve regeneration, notably neurite outgrowth inhibitors 
and myelin-associated glycoproteins [3].  Recently, stem cell 
research has provided hope for replacing lost neuronal cells 
for several neurodegenerative diseases and CNS injuries. 
Functional recovery following brain and spinal cord injuries 
likely require the transplantation of exogenous stem cells 
either neural stem cells (NSCs)/human mesenchymal stem 
cells (hMSCs), since the mammalian CNS has little capacity 
for self-repair [4-7].
Stem cells are defined as self-renewing, primordial 
cells possessing the capacity to give rise to a differentiated 
Introduction
Advances in nanomedicine are expected to have a major 
impact in neurological research, contributing to our further 
understanding of the central nervous system (CNS) and the 
development of novel therapeutic strategies for neurological 
intervention [1, 2]. CNS has limited regenerative potential 
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progeny with all neural lineages, and are posited to exist in 
embryonic and fetal germinal zones and participate in CNS 
organogenesis [8, 9]. The subventricular zone (SVZ) is a 
dynamic place serving as the most predominant source of 
adult neurogenesis. But axon regeneration and functional 
re co very do not occur in the CNS due to a post-injury in-
crease in inhibitors of axon extension, leading to permanent 
disability [3]. Normal axon growth and guidance is regulated 
by extracellular cues that promote or inhibit advance of the 
tip of an extending axon (the growth cone) [3]. It is known 
that cells with stem cell-like characteristics can be isolated 
from the mammalian CNS at all ages, propagated in culture, 
and reimplanted into injured CNS regions to compensate the 
damaged neurons within the injury site [3, 8, 10-13]. 
But the transplantation of stem cells has limitations, 
because of low survival rate at the injury sites [6]. Several 
methodologies were developed to enhance the efficacy of 
the stem cells to withstand the pathological situation around 
the injury site during transplantation. Among the various 
methodologies used, one of the promising approaches is 
building biocompatible substitutes for efficient culture of 
stem cells to repair or replace the function of damaged nerve 
tissues [14-16]. Among the various biomaterials available, 
exploitation of carbon nanotubes (CNTs) is one of the 
most attractive candidates for neurological applications. 
During the last decade, CNTs have shown evidence of their 
electrical conductive capacity, strong mechanical properties 
and morphological similarity to neurites [17] leading to 
the advancements for tissue engineering and regenerative 
medicine using CNT based stem cells for tissue repair. CNTs 
have unique advantages in controlling stem cell function 
and in tissue regeneration [18] due to their biomimetic 
characteristics and special biological and mechanical 
properties [19]. In the past, stem cell therapy seemed like it 
may present a cure for all medical ailments, but problems such 
as immune system clearance, control of differentiation in the 
body, etc  have hindered progress. However, with the synergy 
of carbon nano-dimensional materials, researchers have been 
able to overcome these tissue engineering and regenerative 
medicine obstacles and have begun developing treatments for 
strokes, bone failure, cardiovascular disease, and many other 
ailments.  Application of nanomaterials including CNTs in the 
biomedical field provides a provision of an appropriate nano-
biointerface for the control of cellular behavior, and, therefore, 
optimizes tissue regeneration [20, 21]. 
As stated above, over the past few decades there have 
been significant advances in stem cell therapy and tissue 
engineering for the repair and replacement of damaged tissue 
and organs. In parallel, nanotechnology and nanomaterials, 
in particular CNTs have emerged showing a pronounced 
potential for creating the next generation of biomaterials.
Characteristics of CNTs to Support Neuronal 
Differentiation
CNTs structural features and dimensions are very much 
similar to many elements of the neuronal network (ion 
channels, signaling proteins and elements of the neuronal 
cytoskeleton) enabling the use of CNTs at the molecular 
level and consequently better control over physiological 
activity and neuronal information processing [22]. The CNTs 
structural backbone is exclusively composed of carbon atoms 
and exhibits exceptional properties, such as high electronic 
and thermal conductivity as well as great strength. Two main 
types of CNTs have been explored in biomedicine: 1) single-
walled nanotubes (SWNT), consisting of a single sheet of 
carbon benzene rings rolled up into a tubular structure; and 
2) multi-walled nanotubes (MWNT) that consist of multiple 
concentric layers of carbon sheets. CNTs (pristine carbon 
nanotubes) are insoluble in most aqueous solvents and the 
development of functionalization chemistries of the nanotube 
surface led to a notable enhancement in aqueous dispersibility 
that has allowed their application in physiological environ-
ments including the CNS [23]. Two main strategies have 
been described to enable the application of CNTs under 
physiological conditions, namely non-covalent and covalent 
functionalization [24]. Non-covalent functionalization 
involves the coating of nanotubes with hydrophilic macro-
molecules and the introduction of repulsive forces [25]. This 
has been achieved by coating or wrapping the CNT with 
surfactants [26] such as, polymers [26], peptides [27], or 
single stranded DNA [28]. 
Covalent modifications of CNTs, could increase the 
retention of an attached compound/group and play important 
role in brain signaling. A study report suggested that, nerve 
growth factor and brain-derived neurotrophic factor, and 
co-polymer covalently bound to SWNTs/MWNTs, could be 
used to regulate the growth of neurons [29] indicating that 
biologically active molecules like neurotrophins attached 
to CNTs can retain their activity and interact with cells to 
promote their function [30].  
Previous studies suggest that CNT substrates can boost 
CNTs and their application in CNS injuries
http://dx.doi.org/10.5115/acb.2013.46.2.85
Anat Cell Biol 2013;46:85-92 87
www.acbjournal.org
neuronal electrical signaling [31], decrease astrocyte for-
mation, macrophage density (cells which synthesize 
unwanted glial scar tissue in the brain) [32] and shown 
to increase the differentiation of NSCs to neurons [33] 
suggesting the promise for the use of CNTs as novel stem 
cell delivery vehicles for treating stroke damaged neural 
tissue [34, 35] in vivo.  These attractive properties of CNTs 
have been attributed due to their unique conductivity and 
surface energetics capable of promoting the adsorption of 
endogenous proteins important for mediating cell adhesion 
(particularly the adsorption of vitronectin and fibronectin) 
in the transplanted region [36-38]. Importantly, CNTs have 
been exploited because of their “cell-friendly” nature which 
aids in promoting the functions of damaged neurons [32]. 
Specifically, researchers have developed micron patterns 
of CNTs on polymers such as polycarbonate urethane 
(PCU), which enable neuron cell attachment and extension 
of neurites along CNTs. These results highlight the ability 
of CNTs to direct functions of neurons to potentially heal 
damaged neural tissue [32, 33, 39]. 
Affinity of CNTs for Supporting the Growth of 
Neurons, In Vitro
CNTs are unique formulations that provide a window of 
opportunity for designing more successful neural friendly 
materials (Figs. 1, 2). Previous studies reported the growth 
of astrocytes and microglias on CNT and PCU materials. 
The microglia preferred a PCU surrounding rather than 
CNT. However, many studies reported that the growth of the 
Fig. 1. (A) Scanning electron microscope image of aligned carbon nanotube at ×50. (B, C) Fluorescence images of the primary neural cells 
adhesion on aligned carbon nanotubes (CNTs) after 24 hours. (D, E) Fluorescence images of the subventricular zone neural stem cells adhesion on 
aligned CNTs. Cells were visualized by the use of DAPI stain. (F, G) Fluorescence images of the PC12 cells adhesion on aligned CNT rather than 
polycarbonate urethane (PCU) after 24 hours. Cells were visualized by the use of DAPI stain. Phase images of the selective macrophage adhesion (H) 
and activation (I) on aligned PCU rather than CNT after 24 hours. CNTs appear black. Scale bars=50 µm (A, B, D, F, H), 100 µm (C, E, G, I).
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neuron preferred a CNT surrounding to a PCU one [33, 34, 
39, 40]. The origin of the neuron-CNT interaction appears to 
be strongly affected by surface roughness. It was demonstrated 
that the roughness of CNTs contributes to anchoring the 
neuronal cells [41]. Zhang et al. [42] preferentially cultured 
neuronal cell line H19-7 on the MWNT patterns. Neuronal 
growth cones were found to make contact with the nanotube 
surface, and these strong interactions allowed the neurons 
to spread long patterns and form interactions with one 
another. Additional mechanism may be that long nanotubes 
are flexible and undergo deformation to accommodate the 
proliferating neurites [42]. 
Biocompatability of CNTs to Manipulate Stem 
Cells for Treating CNS Injuries
CNTs are often modified to improve their biocompatibility 
to perform new functions by tagging various compounds to 
them. Lipids, DNA and various peptides can often be simply 
adsorbed to the CNT. If a more permanent attachment is 
desired, compounds may be covalently linked to CNTs by 
incubating CNTs with strong oxidizing agents like nitric 
acid, which add carboxyl groups to the ends of the CNTs. 
In addition other groups can then be added converting the 
carboxyl group to acyl chloride, which can then be reacted 
with the compound of interest [43-45]. CNTs have been 
studied as substrates for neuronal growth. Their size and 
shape are similar to neuronal processes and can be made 
conductive. These are all qualities that are advantageous for 
creating scaffolds for neuronal growth [46]. CNTs are not 
biodegradable, and as such they could be used as implants 
where long-term extracellular molecular cues for neurite 
outgrowth are necessary, such as in regeneration after spinal 
cord or brain injury [47]. Several studies demonstrated 
Fig. 2. (A) Stem cell interaction with carbon nanotubes (CNTs) one week after implantation into stroke damaged rat neural tissue. Results of this 
in vivo data showed increased expression of NeuN (marker for neurons) (B), nestin (marker for stem cells) (C) and decreased the expression of the 
astrocytes formation evidenced by less glial fibrillary acidic protein (GFAP) positive cells surrounding the carbon nanofibers  (which appears black 
in the histological sections) (D). Scale bars=25 µm (B–D).
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the usage of CNTs as permissive substrates/scaffolds for 
cell adhesion and growth. The first study that explored 
the possibility of using CNTs as substrates for neuronal 
growth was done by Mattson and colleagues [46]. They grew 
embryonic rat hippocampal neurons on MWNTs [46] and 
results showed that the neurons grown on MWNTs displayed 
an increased number, length, and branching of neurites 
suggesting that MWNTs can serve as a permissive substrate 
for neuronal cell adhesion and growth. In a follow-up study 
[48] surface charge of MWNTs were systematically varied to 
control the outgrowth and branching pattern of neuronal pro-
cesses. Hu et al. [48] examined the morphological parameters 
of live rat neonatal hippocampal neurons in cultures using 
calcein dye. Their results using live cells were consistent with 
the initial finding by Mattson and colleagues using fixed cells.
Liopo et al. [49] demonstrated that SWNTs were less sup-
portive to neural cell attachment and growth than unfunc-
tionalized nanotubes. Furthermore, Galvan-Garcia et al. [50] 
reported that directionally oriented CNTs promoted cell 
attachment, differentiation and cell growth. Additionally, 
when highly purified, these CNTs supported the survival 
of neurons to extend processes and length suggesting that 
interaction between neurons and CNTs may be affected 
by the purity of CNTs as well as by the 3-dimensional 
organization of the CNT substrate/scaffold. Interestingly, 
carbon threads made from SWNTs [51] were also compatible 
with neural cells as demonstrated by culturing hippocampal 
neurons and PC12 cells on them. After a week in culture, 
neurite outgrowth on the nanothread surface showed neuron 
specific labelling (β111 tubulin staining) indicating the 
biocompatibility of these nanothreads for the construction 
of electrodes or nanowires in implantable devices.  Gabay 
et al. [52] designed a micropatterned array of CNTs (coated 
with dimethyl siloxane) to study self-organization of 
neural networks. The neurons grown on these substrates 
had accumulated on the CNTs within 4 days showing 
neuronal processes. Similarly, Sorkin et al. [53] cultured 
hippocampal neurons on the polydimethylsiloxane stencil 
coated CNTs substrates and the results showed islands with 
neurites with in 2 to 3 days during culture. These patterned 
networks could be used to study neuronal networking with 
CNTs as electrical connections for sensing or stimulation. 
Additionally, there have been some attempts to use CNTs 
in stem cell research. The growth and differentiation of 
NSCs on nanotube substrates was recently demonstrated 
[54]. Coverslips coated with six layers of SWNTs dispersed 
in sodium 4-styrene-sulfonate were used to culture NSCs. 
Cells adhered and differentiated into neurons, astrocytes and 
oligodendrocytes as shown by immunoreactivity with nestin, 
microtubule-associated protein 2 (anti-MAP2), glial fibrillary 
acidic protein (anti-GFAP), and oligodendrocyte marker O4 
(anti-O4). Since there was no adverse effects of growing on 
nanotube substrates these materials could readily be used for 
applications involving stem cells. Previously, it was reported 
that CNTs can increase the differentiation efficiency of 
NSCs to neurons [33] and the unique formulations of CNTs 
decreases the macrophage activation indicating the promise 
for the use of CNTs as novel stem cell delivery vehicles for 
treating stroke damaged neural tissue [34, 35]. Park et al. [6] 
used postnatal mouse hypoxic-ischemic model to combine 
biomaterials science and stem cell biology in the brain [9, 
14]. After such a severe ischemic event, scaffolding, such 
as with polyglycolic acid, a biodegradable polymer, would 
provide the support system in which multipotent stem cells 
could begin to integrate with a very hostile environment 
and ultimately contribute to CNS tissue reconstitution [14]. 
Stem cells seeded with biomaterials acquire some degree of 
cyto-architectural organization and generate appropriate 
synaptic interconnectivity with the host [9]. Recent studies 
demonstrate that CNTs impregnated with subventricular 
neural progenitor cells with a structural environment to 
differentiate and migrate into the injured tissue and minimize 
the reactive microglial cells around the ischemic core region 
[39]. Several studies have already shown the ability of CNTs 
based substrates to mediate the differentiation and electrical 
stimulation of NSCs [54, 55]. The NSCs have been shown 
to be biocompatible with CNT substrates with levels of cell 
viability and the development of neural processes [55]. The 
effectiveness of carbon CNTs to deliver NSCs into CNS-
injured sites, and support their differentiation into neurons, 
constitutes an essential requirement for the success of 
regeneration of damaged neural tissues (Fig. 2). Roman et al. 
[56] demonstrated that SWNT chemically functionalized with 
PEG were effective in the promotion of axonal regeneration 
in a rat model of SCI (at T9 vertebral level). 
Toxicity of CNTs in Medical Applications
The use of CNTs in medicine has raised interest in their 
potential toxicity. The effect of CNTs on living systems 
has become a highly active area of research over the last 
decade [57, 58]; however, there is still no broad consensus 
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on what features of nanoparticles make them more or less 
biocompatible. Biocompatible nanomaterials are being 
developed for many cell- and tissue-contacting applications, 
and therefore biocompatibility is necessarily an important 
issue. Some of these materials, including CNTs, are rapidly 
approaching targeted clinical use [1, 59] and it is highly likely 
that CNTs will find medical uses. However it has become 
clear that it is impossible to broadly classify CNT as ‘nontoxic’ 
or ‘toxic,’ since their effects on cells are highly dependent on 
the application. In this respect they are very similar to most 
other molecules and materials that are used in medicine: their 
efficacy and side effects depend greatly on the dose, mode 
of administration and type of exposure. In spite of these 
concerns, it is likely that CNTs will find utility as experimental 
tools in neuroscience and in addition will form the basis of 
new technologies in neuromedicine.
Future Perspective
CNT/NSCs/MSCs composites, in which CNTs are com-
bined with stem cells as base material, were developed 
to improve the neurite growth during CNS damages. 
Applications of CNTs both in vivo and in vitro study showed 
similar biocompatibility ability of CNTs impregnated 
with stem cells which could direct functions of neurons 
to potentially heal damaged neural tissue. The use of 
biomaterials in treatment of brain disorders and spinal cord 
injury may require advances in both neurobiology and 
scaffolds, but advances in in vitro uses will almost certainly 
underpin therapeutic applications.
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